[Use of antihistaminic drugs in the treatment of allergic rhinopathies].
D000799:Angioedema / Q000188:drug therapy; D001593:Benzyl Compounds / Q000627:therapeutic use; D003875:Drug Eruptions / Q000188:drug therapy; D004485:Eczema / Q000188:drug therapy; D005021:Ethylamines / Q000627:therapeutic use; D005029:Ethylenediamines / Q000627:therapeutic use; D006634:Histamine H1 Antagonists / Q000627:therapeutic use*; D006801:Humans; D008881:Migraine Disorders / Q000188:drug therapy; D010276:Parasympatholytics / Q000627:therapeutic use; D010632:Pheniramine / Q000627:therapeutic use; D011398:Promethazine / Q000627:therapeutic use; D012130:Respiratory Hypersensitivity / Q000188:drug therapy*; D014581:Urticaria / Q000188:drug therapy
D001593:Benzyl Compounds; D005021:Ethylamines; D005029:Ethylenediamines; D006634:Histamine H1 Antagonists; D010276:Parasympatholytics; D010632:Pheniramine; D011398:Promethazine
Utilizarea medicamentelor antihistaminice în tratamentul rinopatiilor alergice.